Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets.
about
Recent advances in proximal gastric carcinoma.Dual role of cAMP in the transcriptional regulation of multidrug resistance-associated protein 4 (MRP4) in pancreatic adenocarcinoma cell lines.Bioresponsive antisense DNA gold nanobeacons as a hybrid in vivo theranostics platform for the inhibition of cancer cells and metastasis.p21-activated kinase 1 (PAK1) expression correlates with prognosis in solid tumors: A systematic review and meta-analysisGastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1- facilitated MMP-14 expressionScreening Driving Transcription Factors in the Processing of Gastric Cancer.TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.ITGBL1 Predicts a Poor Prognosis and Correlates EMT Phenotype in Gastric Cancer.Adaptive and reversible resistance to Kras inhibition in pancreatic cancer cells.SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis.Intratumor stromal proportion predicts aggressive phenotype of gastric signet ring cell carcinomas.Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer
P2860
Q30251478-919B342C-3133-4BEC-A224-D0916A02BDB6Q35195574-6D71D52B-A9BE-417B-9322-AB099D82C6B0Q35865494-95A9039C-54DC-4711-A7AE-82702C0924EDQ37317276-843AF043-3899-4FF0-9AD5-5E35A4304B27Q38527414-AED7EE2A-61F2-4454-B393-83510C270991Q38615332-B6BCA5CC-2ECE-4BD4-A6F5-BBD9907497C2Q42160706-C7B7CF96-D635-45C7-A328-EE5BF22B261BQ47126606-E5F815FF-3488-47BA-B945-E692FD1CD152Q47146571-30976187-EDA5-4CD8-94A2-3264F783B501Q47217864-9A2FEEF7-F5C2-4688-A252-B9DEE840E045Q47221572-07978BFD-2E7D-4100-A1C2-02509F6AB06DQ47944019-CCCA6365-8576-4A9B-8AAB-6D459AB49C6BQ58801774-4036BE39-9F5E-4029-ABD7-87D4D1F37135
P2860
Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Whole genome gene copy number ...... lification as therapy targets.
@en
Whole genome gene copy number ...... lification as therapy targets.
@nl
type
label
Whole genome gene copy number ...... lification as therapy targets.
@en
Whole genome gene copy number ...... lification as therapy targets.
@nl
prefLabel
Whole genome gene copy number ...... lification as therapy targets.
@en
Whole genome gene copy number ...... lification as therapy targets.
@nl
P2093
P2860
P356
P1476
Whole genome gene copy number ...... lification as therapy targets.
@en
P2093
Beirong Gao
Chunlei Huang
Guanshan Zhu
Jiangang Fu
Lianhai Zhang
P2860
P304
P356
10.1002/GCC.22196
P50
P577
2014-06-17T00:00:00Z